CE Mogensen - Journal of internal medicine, 2003 - ingentaconnect.com Over the past decade, there has been considerable focus on the concept of
microalbuminuria, not only because it predicts renal disease in type 1 and type
2 diabetes, but also because it relates to premature mortality in the ... Cited by 145 - Related articles - BL Direct - All 7 versions
- ►asnjournals.org WA Wilmer, BH Rovin, CJ Hebert, SV Rao, K … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol ABSTRACT. It is widely accepted that proteinuria reduction is an appropriate
therapeutic goal in chronic proteinuric kidney disease. Based on large
randomized controlled clinical trials (RCT), ACE inhibitor (ACEI) and ... Cited by 106 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org [PDF] DK Arnett, BR Davis, CE Ford, E Boerwinkle, C … - Circulation, 2005 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Enzyme Insertion/Deletion Polymorphism ... Cited by 55 - Related articles - All 14 versions
KJ Schjoedt, S Andersen, P Rossing, L … - Diabetologia, 2004 - Springer Aims/hypothesis. It has been suggested that aldoster- one plays a role in the
initiation and progression of re- nal disease independently of arterial blood
pressure and plasma angiotensin II levels. We evaluated the in- fluence of ... Cited by 46 - Related articles - All 4 versions
F SA, PR LT, LW KR, HP RG - Kidney international, 2005 - nature.com Seventy-one hypertensive type 1 diabetic patients with diabetic nephropathy were
included in the study. After a washout period of 4 weeks, the patients received
Losartan 50 mg, 100 mg, and 150 mg once daily in treatment periods each ... Cited by 34 - Related articles - All 3 versions
P Jacobsen, K Rossing, HH Parving - Current opinion in nephrology and hypertension, 2004 - journals.lww.com Purpose of review Antihypertensive treatment has improved renal prognosis and
survival in diabetic nephropathy. The present review summarizes the current
status of blockade of the renin– angiotensin system in diabetic ... Cited by 31 - Related articles - BL Direct - All 7 versions
P Jacobsen, HH Parving - Kidney International, 2004 - nature.com Compared to ACE-I, dual blockade of the RAS decreased albuminuria 37% from 558
mg/24 hour, and lowered 24-hour blood pressure 7/5 mm Hg from 137/76 mm Hg (P <
0.01). In addition, dual blockade lowered total and LDL-cholesterol 0.3 ... Cited by 17 - Related articles - All 4 versions
KJ Schjoedt, P Jacobsen, K Rossing, F … - Hormone and metabolic research, 2005 - cat.inist.fr Dual blockade of the renin-angiotensin-aldosterone system(RAAS) with both ACE
inhibitors and angiotensin II receptor-blockers has been shown to reduce both
albuminuria and blood pressure compared to either monotherapy. The ... Cited by 17 - Related articles - All 3 versions
P Hovind, L Tarnow, HH Parving - Current Hypertension Reports, 2004 - Springer Introduction Diabetic nephropathy is characterized by arterial blood pres- sure
elevation, increasing albuminuria, and a relentless decline in kidney function,
and is regarded as an irreversible and rapidly progressive disease with ... Cited by 16 - Related articles - BL Direct - All 3 versions
